Alykhan Motani

1.9k total citations · 1 hit paper
18 papers, 1.5k citations indexed

About

Alykhan Motani is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Alykhan Motani has authored 18 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Alykhan Motani's work include Growth Hormone and Insulin-like Growth Factors (4 papers), Platelet Disorders and Treatments (2 papers) and Retinal Diseases and Treatments (2 papers). Alykhan Motani is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (4 papers), Platelet Disorders and Treatments (2 papers) and Retinal Diseases and Treatments (2 papers). Alykhan Motani collaborates with scholars based in United States, United Kingdom and Switzerland. Alykhan Motani's co-authors include Gordon A. Ferns, Elaine W. Raines, M A Reidy, K. H. Sprugel, Erik Änggård, G. Ferns, Qingxiang Liu, Steven Whitebread, B. Kamber and Marc de Gasparo and has published in prestigious journals such as Science, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Alykhan Motani

17 papers receiving 1.4k citations

Hit Papers

Inhibition of Neointimal Smooth Muscle Accumulation After... 1991 2026 2002 2014 1991 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alykhan Motani United States 13 764 295 293 218 217 18 1.5k
Stephan Goetze Germany 22 1.3k 1.7× 396 1.3× 261 0.9× 385 1.8× 252 1.2× 38 2.1k
Chu Kataoka Japan 14 390 0.5× 334 1.1× 312 1.1× 171 0.8× 389 1.8× 17 1.3k
Nirav Dhanesha United States 24 497 0.7× 135 0.5× 172 0.6× 155 0.7× 340 1.6× 53 1.3k
Jerzy‐Roch Nofer Germany 13 749 1.0× 201 0.7× 381 1.3× 165 0.8× 247 1.1× 23 1.5k
Amy Mohan United States 20 762 1.0× 365 1.2× 260 0.9× 89 0.4× 373 1.7× 28 1.4k
Patrizia Dentelli Italy 26 1.1k 1.4× 183 0.6× 179 0.6× 606 2.8× 401 1.8× 47 1.9k
Keyvan Mahboubi United States 15 700 0.9× 205 0.7× 119 0.4× 173 0.8× 331 1.5× 22 1.3k
Bernadette Bonardo France 18 501 0.7× 95 0.3× 158 0.5× 199 0.9× 212 1.0× 24 1000
Kathy J. Carter United States 12 424 0.6× 145 0.5× 328 1.1× 307 1.4× 468 2.2× 13 1.2k
Eric A. Shikatani Canada 12 589 0.8× 234 0.8× 263 0.9× 126 0.6× 607 2.8× 13 1.5k

Countries citing papers authored by Alykhan Motani

Since Specialization
Citations

This map shows the geographic impact of Alykhan Motani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alykhan Motani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alykhan Motani more than expected).

Fields of papers citing papers by Alykhan Motani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alykhan Motani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alykhan Motani. The network helps show where Alykhan Motani may publish in the future.

Co-authorship network of co-authors of Alykhan Motani

This figure shows the co-authorship network connecting the top 25 collaborators of Alykhan Motani. A scholar is included among the top collaborators of Alykhan Motani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alykhan Motani. Alykhan Motani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Collibee, Scott E., Chih-Yuan Chuang, James J. Hartman, et al.. (2024). Discovery of Nelutroctiv (CK-136), a Selective Cardiac Troponin Activator for the Treatment of Cardiovascular Diseases Associated with Reduced Cardiac Contractility. Journal of Medicinal Chemistry. 67(10). 7825–7835. 6 indexed citations
2.
Collibee, Scott E., Alexander R. Muci, Darren T. Hwee, et al.. (2024). Cardiac Troponin Activator CK-963 Increases Cardiac Contractility in Rats. Journal of Medicinal Chemistry. 67(10). 7859–7869. 2 indexed citations
3.
Slater, Rebecca, Jinghong Wang, Chen Wang, et al.. (2022). Distinct Mechanisms for Increased Cardiac Contraction Through Selective Alteration of Either Myosin or Troponin Activity. JACC Basic to Translational Science. 7(10). 1021–1037. 1 indexed citations
4.
Wang, Yingcai, Richard Connors, Pingchen Fan, et al.. (2014). Structure-assisted discovery of the first non-retinoid ligands for Retinol-Binding Protein 4. Bioorganic & Medicinal Chemistry Letters. 24(13). 2885–2891. 14 indexed citations
5.
Motani, Alykhan, Jian Luo, Lingming Liang, et al.. (2013). Evaluation of AMG 076, a potent and selective MCHR1 antagonist, in rodent and primate obesity models. Pharmacology Research & Perspectives. 1(1). e00003–e00003. 9 indexed citations
6.
Fan, Pingchen, Xiaoqi Chen, Xi Chen, et al.. (2012). Discovery of a novel melanin concentrating hormone receptor 1 (MCHR1) antagonist with reduced hERG inhibition. Bioorganic & Medicinal Chemistry Letters. 22(11). 3781–3785. 14 indexed citations
7.
Yu, Ming, Mike E. Lizarzaburu, Holger Beckmann, et al.. (2010). Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity. Bioorganic & Medicinal Chemistry Letters. 20(5). 1758–1762. 18 indexed citations
8.
Gu, Wei, Katherine A. Winters, Alykhan Motani, et al.. (2010). Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor. American Journal of Physiology-Endocrinology and Metabolism. 299(4). E624–E632. 45 indexed citations
9.
Motani, Alykhan, Zhulun Wang, Marion Conn, et al.. (2009). Identification and Characterization of a Non-retinoid Ligand for Retinol-binding Protein 4 Which Lowers Serum Retinol-binding Protein 4 Levels in Vivo. Journal of Biological Chemistry. 284(12). 7673–7680. 68 indexed citations
10.
Motani, Alykhan, Zhulun Wang, Jennifer Weiszmann, et al.. (2009). INT131: A Selective Modulator of PPARγ. Journal of Molecular Biology. 386(5). 1301–1311. 98 indexed citations
11.
Chung, Chan D., et al.. (2003). CCR8 Is Not Essential for the Development of Inflammation in a Mouse Model of Allergic Airway Disease. The Journal of Immunology. 170(1). 581–587. 79 indexed citations
12.
Tazuke, Salli I., et al.. (1998). Hypoxia regulation of Insulin-like Growth Factor Binding Protein-1 (IGFBP-1): Potential mechanisms for growth regulation of the IUGR fetus. Journal of the Society for Gynecologic Investigation. 5(1). 160A–160A.
13.
Motani, Alykhan, et al.. (1996). Insulin‐like growth factor‐I modulates monocyte adhesion to EAhy 926 endothelial cells. International Journal of Experimental Pathology. 77(1). 31–35. 18 indexed citations
14.
Motani, Alykhan, Erik Änggård, & Gordon A. Ferns. (1996). Recombinant insulin-like growth factor-1 modulates aggregation in human platelets via extracellular calcium. Life Sciences. 58(15). PL269–PL274. 19 indexed citations
16.
Ferns, Gordon A., et al.. (1991). Inhibition of Neointimal Smooth Muscle Accumulation After Angioplasty by an Antibody to PDGF. Science. 253(5024). 1129–1132. 933 indexed citations breakdown →
17.
Ferns, G., Alykhan Motani, & Erik Änggård. (1991). The insulin-like growth factors: their putative role in atherogenesis.. PubMed. 18(4). 197–225. 50 indexed citations
18.
Gasparo, Marc de, et al.. (1990). Biochemical Characterization of Two Angiotensin II Receptor Subtypes in the Rat. Journal of Cardiovascular Pharmacology. 16(Supplement 4). S31–S35. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026